11968

    532660

    VIVIMEDLAB

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Vivimed Labs Limited Share Price Today

    VIVIMED LABS LIMITED is currently trading at ₹5.22, down by ₹0.03 from the previous close. The stock touched an intraday high of ₹5.35 and a low of ₹5.10 during the latest trading session. Over the past one year, VIVIMED LABS LIMITED has delivered a loss of 79.66%, while the stock has declined 13.02% in the last one month.

    Vivimed Labs Limited performance

    Today’s low Today’s high
    ₹ 5.10 ₹ 5.35
    ₹ 5.25
    52 week low 52 week high
    ₹ 5.15 ₹ 29.40
    ₹ 5.25
    Open Price ₹ 5.35
    Prev. Close ₹ 5.25
    Volume (Shares) 75409.00
    Total traded value ₹ 3.95
    Upper Circuit ₹ 5.51
    Lower Circuit ₹ 4.99
    info

    Investment Returns

    Over 1 Month -13.02% Over 3 Months -26.49% Over 6 Months -45.84% Over 1 Year -79.66%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Vivimed Labs Limited fundamentals


    • Market cap (Cr) 43.50
    • P/E Ratio (TTM) -1.31
    • Beta 0.59
    • Book Value / share 0.91
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -16.57
    info icon alternate text
    • Market cap (Cr) 44.00
    • P/E Ratio (TTM) -1.31
    • Beta 0.50
    • Book Value / share 0.91
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -16.57
    info icon alternate text

    Vivimed Labs Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars DEC 2025 (Values in Cr)
    Revenue 11.63
    Operating Expense 28.19
    Net Profit -16.57
    Net Profit Margin (%) -142.47
    Earnings Per Share (EPS) -2.00
    EBITDA -11.23
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 18.66
    Operating Expense 26.26
    Net Profit -7.45
    Net Profit Margin (%) -39.92
    Earnings Per Share (EPS) -0.90
    EBITDA -1.17
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 17.94
    Operating Expense 23.80
    Net Profit -5.50
    Net Profit Margin (%) -30.65
    Earnings Per Share (EPS) -0.66
    EBITDA -0.18
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 22.58
    Operating Expense 31.15
    Net Profit -4.42
    Net Profit Margin (%) -19.57
    Earnings Per Share (EPS) -0.53
    EBITDA 1.67
    Effective Tax Rate (%) 0.00
    Particulars DEC 2024 (Values in Cr)
    Revenue 34.23
    Operating Expense 41.21
    Net Profit -6.97
    Net Profit Margin (%) -20.36
    Earnings Per Share (EPS) -0.84
    EBITDA -0.16
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 103.60
    Operating Expense 139.28
    Net Profit -31.50
    Net Profit Margin (%) -30.40
    Earnings Per Share (EPS) -3.80
    EBITDA -10.34
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 136.80
    Operating Expense 190.75
    Net Profit -44.38
    Net Profit Margin (%) -32.44
    Earnings Per Share (EPS) -5.35
    EBITDA -24.07
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 176.83
    Operating Expense 507.19
    Net Profit -328.01
    Net Profit Margin (%) -185.49
    Earnings Per Share (EPS) -39.56
    EBITDA -187.94
    Effective Tax Rate (%) 0.64
    Particulars MAR 2022 (Values in Cr)
    Revenue 218.37
    Operating Expense 284.56
    Net Profit -67.75
    Net Profit Margin (%) -31.02
    Earnings Per Share (EPS) -8.17
    EBITDA -7.95
    Effective Tax Rate (%) -4.34
    Particulars MAR 2021 (Values in Cr)
    Revenue 210.05
    Operating Expense 245.54
    Net Profit -29.19
    Net Profit Margin (%) -13.89
    Earnings Per Share (EPS) -3.52
    EBITDA 27.87
    Effective Tax Rate (%) 0.78
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share -8.82
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -7.43
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share -5.24
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -15.36
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 0.17
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 2.25
    EBITDA Margin -99.42
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 39.35
    ROE % -18.80
    ROCE % -2.15
    Total Debt to Total Equity 0.95
    EBITDA Margin -2.76
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 47.47
    ROE % -16.62
    ROCE % -0.93
    Total Debt to Total Equity 1.07
    EBITDA Margin 4.80
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 2.47
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 10.44
    EBITDA Margin -9.97
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 6.20
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 5.13
    EBITDA Margin -17.22
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 11.50
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.43
    EBITDA Margin -106.13
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 50.57
    ROE % -14.96
    ROCE % -2.60
    Total Debt to Total Equity 0.75
    EBITDA Margin -3.56
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 58.67
    ROE % -4.65
    ROCE % 1.87
    Total Debt to Total Equity 0.63
    EBITDA Margin 16.14
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.70
    Total Assets 920.83
    Total Liabilities 920.83
    Total Equity -35.16
    Share Outstanding 8
    Price to Book Ratio 0.00
    Return on Assets (%) -3.47
    Return on Capital (%) -9.37
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 2.02
    Total Assets 950.91
    Total Liabilities 950.91
    Total Equity -5.46
    Share Outstanding 8
    Price to Book Ratio 0.00
    Return on Assets (%) -4.77
    Return on Capital (%) -12.23
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.76
    Total Assets 995.05
    Total Liabilities 995.05
    Total Equity 39.42
    Share Outstanding 8
    Price to Book Ratio 0.58
    Return on Assets (%) -33.01
    Return on Capital (%) -78.6
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 7.18
    Total Assets 1266.01
    Total Liabilities 1266.01
    Total Equity 364.28
    Share Outstanding 8
    Price to Book Ratio 0.29
    Return on Assets (%) -5.34
    Return on Capital (%) -9.35
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 6.43
    Total Assets 1289.33
    Total Liabilities 1289.33
    Total Equity 431.57
    Share Outstanding 8
    Price to Book Ratio 0.27
    Return on Assets (%) -5.57
    Return on Capital (%) -9.49
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.28
    Total Assets 638.95
    Total Liabilities 638.95
    Total Equity 58.49
    Share Outstanding 8
    Price to Book Ratio 0.00
    Return on Assets (%) -4.92
    Return on Capital (%) -7.27
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.14
    Total Assets 681.46
    Total Liabilities 681.46
    Total Equity 89.40
    Share Outstanding 8
    Price to Book Ratio 0.00
    Return on Assets (%) -6.51
    Return on Capital (%) -9.55
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.34
    Total Assets 795.82
    Total Liabilities 795.82
    Total Equity 133.31
    Share Outstanding 8
    Price to Book Ratio 0.58
    Return on Assets (%) -41.21
    Return on Capital (%) -64.32
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 6.77
    Total Assets 1071.78
    Total Liabilities 1071.78
    Total Equity 457.27
    Share Outstanding 8
    Price to Book Ratio 0.29
    Return on Assets (%) -6.32
    Return on Capital (%) -8.32
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 6.01
    Total Assets 1094.83
    Total Liabilities 1094.83
    Total Equity 524.46
    Share Outstanding 8
    Price to Book Ratio 0.27
    Return on Assets (%) -2.12
    Return on Capital (%) -2.75
    Particulars MAR 2025 (Values in Cr)
    Net Income -31.49
    Cash from Operations -1.66
    Cash from Investing -4.53
    Cash from Financing 4.96
    Net change in Cash -1.31
    Free Cash Flow 2.87
    Particulars MAR 2024 (Values in Cr)
    Net Income -45.82
    Cash from Operations -24.08
    Cash from Investing 28.28
    Cash from Financing -6.03
    Net change in Cash -1.73
    Free Cash Flow -22.04
    Particulars MAR 2023 (Values in Cr)
    Net Income -330.65
    Cash from Operations 35.32
    Cash from Investing -4.96
    Cash from Financing -33.78
    Net change in Cash -3.42
    Free Cash Flow 40.29
    Particulars MAR 2022 (Values in Cr)
    Net Income -64.27
    Cash from Operations 27.54
    Cash from Investing -16.41
    Cash from Financing -10.37
    Net change in Cash 0.75
    Free Cash Flow 43.95
    Particulars MAR 2021 (Values in Cr)
    Net Income -75.76
    Cash from Operations 542.20
    Cash from Investing 404.00
    Cash from Financing -1015.33
    Net change in Cash -44.05
    Free Cash Flow 542.20
    Particulars MAR 2025 (Values in Cr)
    Net Income -30.91
    Cash from Operations 5.73
    Cash from Investing -4.05
    Cash from Financing -2.53
    Net change in Cash -0.85
    Free Cash Flow 9.79
    Particulars MAR 2024 (Values in Cr)
    Net Income -44.38
    Cash from Operations -96.52
    Cash from Investing 99.82
    Cash from Financing -5.50
    Net change in Cash -2.20
    Free Cash Flow -93.99
    Particulars MAR 2023 (Values in Cr)
    Net Income -330.12
    Cash from Operations 32.86
    Cash from Investing -1.59
    Cash from Financing -34.69
    Net change in Cash -3.42
    Free Cash Flow 34.46
    Particulars MAR 2022 (Values in Cr)
    Net Income -64.37
    Cash from Operations 25.30
    Cash from Investing -11.33
    Cash from Financing -13.20
    Net change in Cash 0.76
    Free Cash Flow 36.64
    Particulars MAR 2021 (Values in Cr)
    Net Income -29.42
    Cash from Operations 182.01
    Cash from Investing -138.19
    Cash from Financing -46.40
    Net change in Cash -5.07
    Free Cash Flow 246.58
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD. 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LTD. 411.65 18.16 2.97 1211.53 256.40 415.70
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD 521.10 56.34 4.78 5526.59 118.35 552.90

    Vivimed Labs Limited shareholding pattern

    Holding
    90.78%
    7.57%
    1.64%
    15.18%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Vivimed Labs Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    5.25 -2.05 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 5.50
    • 26 Days 5.80
    • 10 Days 5.60
    • 50 Days 6.20
    • 12 Days 5.60
    • 100 Days 6.80
    • 20 Days 5.80
    • 200 Days 8.20
    5.44 PIVOT
    First Support 5.28 First Resistance 5.56 Second Support 5.16 Second Resistance 5.72 Third Support 5.00 Third Resistance 5.84
    RSI 31.23 ADX 48.79 MACD -0.20 Williams % R -89.36 Commodity Channel Index (CCI) -133.23
    Date 2026-04-16 Week 105895.00 Same Day 108652.00 Month 123945.00
    1 Year 0.60 3 Year 0.49
    Over 1 Month
    -13.02% down
    Over 1 Year
    -79.66% down
    Over 3 Months
    -26.49% down
    Over 3 Years
    0.68% down
    Over 6 Months
    -45.84% down
    Over 5 Years
    -26.48% down

    Vivimed Labs Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    19 Sep 2018 0.4 Final 22 Sep 2018 Equity shares
    21 Sep 2017 0.4 Final 23 Sep 2017 Equity shares
    24 Sep 2014 3.0 Final 26 Sep 2014 Equity shares
    24 Sep 2013 3.0 Final 26 Sep 2013 Equity shares
    21 Sep 2012 3.0 Final 25 Sep 2012 Equity shares
    26 Sep 2011 2.0 Final 28 Sep 2011 Equity shares
    09 Sep 2010 1.5 Final 14 Sep 2010 Equity shares
    24 Sep 2009 1.5 Final 28 Sep 2009 Equity shares
    22 Sep 2008 1.0 Final 24 Sep 2008 Equity shares
    Ex-Date Old FV NEW FV Record Date
    06 Apr 2016 10.0 2.0 08 Apr 2016
    Dividend date Dividend amount Dividend type Record date Instrument type
    19 Sep 2018 0.4 Final 22 Sep 2018 Equity shares
    21 Sep 2017 0.4 Final 23 Sep 2017 Equity shares
    24 Sep 2014 3.0 Final 26 Sep 2014 Equity shares
    24 Sep 2013 3.0 Final 26 Sep 2013 Equity shares
    21 Sep 2012 3.0 Final 25 Sep 2012 Equity shares
    26 Sep 2011 2.0 Final 28 Sep 2011 Equity shares
    09 Sep 2010 1.5 Final 14 Sep 2010 Equity shares
    24 Sep 2009 1.5 Final 28 Sep 2009 Equity shares
    22 Sep 2008 1.0 Final 24 Sep 2008 Equity shares
    Ex-Date Old FV NEW FV Record Date
    06 Apr 2016 10.0 2.0 08 Apr 2016

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Vivimed Labs Ltd?

    Answer Field

    Vivimed Labs Ltd share price is for NSE ₹ 5.22 & for BSE ₹ 5.24 as on Jul 15 2026 12:30 PM.

    What is the Market Cap of Vivimed Labs Ltd Share?

    Answer Field

    The market cap of Vivimed Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 15 2026 12:30 PM.

    What is the 52 Week High and Low of Vivimed Labs Ltd?

    Answer Field

    The 52 Week High and Low of Vivimed Labs Ltd for NSE is ₹ 29.40 and ₹ 5.15 and for BSE is ₹ 27.99 and ₹ 5.15.

    What is 1 year return for Vivimed Labs Ltd?

    Answer Field

    The 1 year returns on the stock has been -79.84%.

    What is the P/E Ratio of Vivimed Labs Ltd Share?

    Answer Field

    As on Jul 15 2026 12:30 PM the price-to-earnings (PE) ratio for Vivimed Labs Ltd share is -1.31.

    What is the PB ratio of Vivimed Labs Ltd Share?

    Answer Field

    As on Jul 15 2026 12:30 PM, the price-to-book (PB) ratio for Vivimed Labs Ltd share is 0.91.

    How to Buy Vivimed Labs Ltd Share?

    Answer Field

    You can trade in Vivimed Labs Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Vivimed Labs Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Vivimed Labs Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Vivimed Labs Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |